Source: Contraception. Unidades: FCFRP, FMRP
Subjects: ARTERIOSCLEROSE, DISPOSITIVOS ANTICONCEPCIONAIS (COMBINAÇÃO;EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STOCCO, Bianca et al. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study. Contraception, v. 86, n. 5, p. 506-510, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2012.03.013. Acesso em: 26 set. 2024.APA
Stocco, B., Fumagalli, H. F., Franceschini, S. A., Martinez, E. Z., Marzocchi-Machado, C. M., & Toloi, M. R. T. (2012). Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study. Contraception, 86( 5), 506-510. doi:10.1016/j.contraception.2012.03.013NLM
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MRT. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study [Internet]. Contraception. 2012 ; 86( 5): 506-510.[citado 2024 set. 26 ] Available from: https://doi.org/10.1016/j.contraception.2012.03.013Vancouver
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MRT. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study [Internet]. Contraception. 2012 ; 86( 5): 506-510.[citado 2024 set. 26 ] Available from: https://doi.org/10.1016/j.contraception.2012.03.013